Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
675 N Saint Clair St
Suite 19-100
Chicago, IL 60611Phone+1 312-695-4965- Is this information wrong?
Summary
- HFpEF, cardiac amyloid, pulmonary hypertension, clinical trials, clinical physiologic studies (deep phenotyping), machine learning, precision therapeutics
Education & Training
- University of ChicagoFellowship, Cardiovascular Disease, 2006 - 2007
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 2004 - 2006
- University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
- Northwestern University The Feinberg School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - Present
- IL State Medical License 2006 - 2023
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Ranolazine and Pulmonary Hypertension Start of enrollment: 2010 Jun 01
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Start of enrollment: 2011 Sep 15
- Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy...Mats Christian Højbjerg Lassen, John W Ostrominski, Silvio E Inzucchi, Brian L Claggett, Ian Kulac, Pardeep Jhund, Rudolf A de Boer, Adrian F Hernandez, Mikhail N Kosi...> ;European Journal of Heart Failure. 2024 May 15
- Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trial.Brian L Claggett, Carolyn S P Lam, Michele Senni, Adriaan A Voors, Faiez Zannad, Pardeep S Jhund, Prabhakar Viswanathan, Antonieta Bomfim Wirtz, Patrick Schloemer, Jam...> ;European Journal of Heart Failure. 2024 May 14
- Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.Melanie Davies, Mark C Petrie, Subodh Verma, Shachi Patel, Khaja M Chinnakondepalli, Mette N Einfeldt, Thomas J Jensen, Søren Rasmussen, Rabea Asleh, Tuvia Ben-Gal, Sa...> ;European Heart Journal. 2024 May 13
- Join now to see all
Journal Articles
- Clinical Research Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients with Preserved Ejection FractionSanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, Daniel Burkhoff, ScienceDirect
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients with Heart Failure with Preserved Ejection FractionGregory D Lewis, David J Whellan, Martin M LeWinter, Margaret M Redfield, Andrew L Smith, Eugene Braunwald, Michael M Givertz, Adrian F Hernandez, Sanjiv J Shah, Horng..., JAMA
- Clinical Research History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart FailureJaved Butler, Margaret M Redfield, Adrian F Hernandez, Muthiah Vaduganathan, Ravi B Patel, Sanjiv J Shah, ScienceDirect
- Join now to see all
Lectures
- CorviaCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/12/2019
- Corvia for HFpEF (REDUCE LAP II)CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
- Iatrogenic ASD Devices for Heart Failure: Proof of Principle and Potential Impact on Patient Care2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Press Mentions
- Top 3 Breakthroughs Podcasts of 2022December 19th, 2022
- Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical TrialMay 23rd, 2022
- Corvia Medical’s Atrial Shunt Evaluated in REDUCE LAP-HF II Randomized Clinical TrialFebruary 1st, 2022
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Northwestern Memorial HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: